Medically eligible women who do not use HAART: the importance of abuse, drug use, and race

American Journal of Public Health
Mardge H CohenTracey E Wilson

Abstract

We investigated the prevalence and characteristics of HIV-positive women who do not report highly active antiretroviral therapy (HAART) use. We analyzed HAART use among 1165 HIV-positive participants in the Women's Interagency HIV Study. Between October 1, 2000, and March 31, 2001, 254 women with clinical indications for HAART reported not using it, 635 reported HAART use, and 276 had no clinical indications. In multivariate analysis, using crack/cocaine/heroin and a history of abuse decreased the likelihood of using HAART, whereas being White increased it. One of 4 women for whom HAART was indicated reported not using HAART. Childhood sexual abuse prevention, more intensive abuse treatment, and continuing drug treatment may enhance HIV disease treatment of women.

References

Mar 21, 1998·Epidemiology·S E BarkanJ Feldman
Jan 27, 2000·JAMA : the Journal of the American Medical Association·C C CarpenterP A Volberding
Feb 7, 2001·American Journal of Public Health·M CohenS Melnick
Jun 24, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·L M BogartJ M Sosman
Nov 7, 2000·American Journal of Preventive Medicine·L A McNuttI Fraiser
May 22, 2001·AIDS Patient Care and STDs·L MaiselsC Tobias
Jul 21, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·G M LucasR D Moore
Sep 11, 2001·American Journal of Epidemiology·N A HessolUNKNOWN Women's Interagency Human Immunodeficiency Virus Collaborative Study Group
Nov 15, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·L C HsuS K Schwarcz
Jan 5, 2002·American Journal of Public Health·Judith A CookMary Young
Jan 10, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Lytt I GardnerUNKNOWN HIV Epidemiology Research Study Group
Jan 29, 2002·Journal of Epidemiology and Community Health·S J GangeUNKNOWN Women's Interagency HIV Study Collaborative Study Group
Feb 8, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Antonia L MooreAndrew N Phillips
Jun 6, 2002·Journal of General Internal Medicine·Julia H ArnstenEllie E Schoenbaum
Jul 26, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Judith A CookMary Young
Nov 15, 2002·The New England Journal of Medicine·Mitchell D WongSusan L Ettner

❮ Previous
Next ❯

Citations

May 12, 2009·Neuropsychology Review·Pauline M Maki, Eileen Martin-Thormeyer
Dec 14, 2005·Current HIV/AIDS Reports·Thomas P GiordanoRichard M Grimes
Apr 25, 2012·Current HIV/AIDS Reports·Mariam Aziz, Kimberly Y Smith
Jan 27, 2010·Journal of Consulting and Clinical Psychology·Nancy M PetryKevin Dieckhaus
Oct 23, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elena LosinaKenneth A Freedberg
Oct 9, 2007·AIDS Patient Care and STDs·Michael J MugaveroNathan M Thielman
Jun 23, 2006·AIDS Patient Care and STDs·Chinazo O CunninghamDaliah Heller
Jun 23, 2006·AIDS Patient Care and STDs·Michael MugaveroNathan Thielman
Jul 27, 2010·AIDS Patient Care and STDs·Jennifer L LoganLynette J Menezes
Mar 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mariam Aziz, Kimberly Y Smith
Jan 20, 2011·The Journal of Infectious Diseases·Wendy S Armstrong, Carlos del Rio
Apr 28, 2006·Current Opinion in Psychiatry·Stan Theodorou, Paul S Haber
May 9, 2008·Clinical Obstetrics and Gynecology·Linda R Chambliss
Mar 20, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael J MugaveroMichael S Saag
Jun 3, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Audrey L FrenchMardge H Cohen
Nov 16, 2006·Journal of General Internal Medicine·Barbara J Turner, John A Fleishman
Sep 9, 2005·Clinical and Diagnostic Laboratory Immunology·Melanie C BaconMary A Young
Jun 30, 2012·Systematic Reviews·Georgina SpiesSoraya Seedat
Apr 18, 2009·American Journal of Public Health·Lisa R MetschCarlos del Rio
Sep 9, 2011·Antiviral Therapy·UNKNOWN European Collaborative Study in EuroCoordClaire Thorne
Jan 28, 2014·AIDS Research and Therapy·Erica N JohnsonUNKNOWN Infectious Disease Clinical Research Program HIV Working Group
Apr 15, 2014·AIDS Patient Care and STDs·Rebecca M SchwartzMardge H Cohen
Feb 14, 2007·AIDS and Behavior·Toye H BrewerUNKNOWN ARTAS Study Group
Jan 1, 2014·International Journal of Prisoner Health·Jaimie P MeyerFrederick L Altice
Mar 16, 2006·Journal of Women's Health·Jennifer N SaylesWilliam E Cunningham
Jun 15, 2011·Journal of Women's Health·Jaimie P MeyerFrederick L Altice
Oct 7, 2010·AIDS Care·Shruti RamachandranJessica G Burke
Jun 26, 2013·The Journal of the Association of Nurses in AIDS Care : JANAC·Katherine R SchaferRebecca Dillingham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.